Promis Neurosciences Inc (PMN)

10:41 AM

How dovish Fed policy supports ProMIS Neurosciences Inc. (23J0) stockPortfolio Return Report & Reliable Intraday Trade Plans - ulpravda.ru

10:41 AM

Dec 29, 2025

ProMIS Neurosciences regains Nasdaq compliance - MSN

Dec 29, 2025

Dec 29, 2025

ProMIS Neurosciences to execute 1-for-25 reverse stock split - MSN

Dec 29, 2025

Dec 26, 2025

Promis Neurosciences (NASDAQ:PMN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Dec 26, 2025

Dec 20, 2025

Guidance Update: Will ProMIS Neurosciences Inc. (23J0) stock see valuation expansionWeekly Profit Summary & Community Consensus Trade Signals - Улправда

Dec 20, 2025

Dec 19, 2025

Will ProMIS Neurosciences Inc. (23J0) stock see valuation expansion2025 Volatility Report & Daily Entry Point Trade Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Why ProMIS Neurosciences Inc. (23J0) stock could outperform next yearQuarterly Trade Summary & Consistent Profit Trade Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Why ProMIS Neurosciences Inc. stock appeals to dividend seekers2025 Volume Leaders & Fast Momentum Stock Entry Tips - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Why ProMIS Neurosciences Inc. stock remains on watchlistsGold Moves & Safe Capital Growth Plans - DonanımHaber

Dec 19, 2025

Dec 19, 2025

ProMIS Neurosciences completes enrollment for Alzheimer’s drug trial By Investing.com - Investing.com South Africa

Dec 19, 2025

Dec 18, 2025

ProMIS Neurosciences (PMN) Completes Patient Enrollment for Alzh - GuruFocus

Dec 18, 2025

Dec 18, 2025

ProMIS Neurosciences completes enrollment for Alzheimer’s drug trial - Investing.com

Dec 18, 2025

Dec 18, 2025

ProMIS Neurosciences exceeds target enrollment in Precise-AD phase 1b clinical trial - marketscreener.com

Dec 18, 2025

Dec 18, 2025

ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease - The Manila Times

Dec 18, 2025

Dec 18, 2025

ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 ... - Caledonian Record

Dec 18, 2025

Dec 18, 2025

About Us - FinancialContent

Dec 18, 2025

Dec 16, 2025

ProMIS Neurosciences regains Nasdaq compliance with minimum bid price rule - Investing.com Australia

Dec 16, 2025

Dec 16, 2025

ProMIS Neurosciences Regains Nasdaq Compliance - TipRanks

Dec 16, 2025

Dec 16, 2025

ProMIS Neurosciences regains Nasdaq compliance with minimum bid price rule By Investing.com - Investing.com South Africa

Dec 16, 2025

Dec 14, 2025

ProMIS Neurosciences Announces Third Quarter 2019 Results - PR Newswire

Dec 14, 2025

Dec 13, 2025

ProMIS Neurosciences announces publication highlighting PMN310 - MSN

Dec 13, 2025

Dec 13, 2025

Cash per share of ProMIS Neurosciences Inc. – DUS:23J - TradingView — Track All Markets

Dec 13, 2025

Dec 12, 2025

ProMIS Neurosciences shareholders approve share consolidation proposal By Investing.com - Investing.com Nigeria

Dec 12, 2025

Dec 11, 2025

ProMIS Neurosciences shareholders approve share consolidation proposal - Investing.com

Dec 11, 2025

Dec 10, 2025

ProMIS Neurosciences (PMN) Reveals Promising Study Results for A - GuruFocus

Dec 10, 2025

Dec 10, 2025

ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk - The Manila Times

Dec 10, 2025

Dec 10, 2025

ProMIS Neurosciences Announces New Peer-Reviewed - GlobeNewswire

Dec 10, 2025

Dec 08, 2025

Fortrea (NASDAQ:FTRE) & Promis Neurosciences (NASDAQ:PMN) Head-To-Head Review - Defense World

Dec 08, 2025

Dec 08, 2025

ProMIS Neurosciences: Buy Rating Backed by Innovative EpiSelect™ Platform and Promising PMN310 Candidate - TipRanks

Dec 08, 2025

Dec 06, 2025

Pretax income of ProMIS Neurosciences Inc. – BER:23J - TradingView

Dec 06, 2025

Dec 06, 2025

ProMIS Neurosciences (PMN) Price Target Increased by 2,288.89% to 137.06 - Nasdaq

Dec 06, 2025

Dec 04, 2025

Can ProMIS Neurosciences Inc. (23J0) stock sustain margin levelsJuly 2025 Closing Moves & Weekly Top Gainers Alerts - Newser

Dec 04, 2025

Dec 04, 2025

HC Wainwright Has Strong Forecast for PMN FY2025 Earnings - Defense World

Dec 04, 2025

Dec 03, 2025

How strong is ProMIS Neurosciences Inc. (23J0) stock earnings growth2025 Institutional Moves & Weekly Breakout Watchlists - Newser

Dec 03, 2025

Dec 03, 2025

How geopolitical risks impact ProMIS Neurosciences Inc. (23J0) stock2025 Market Trends & Long-Term Growth Stock Strategies - Newser

Dec 03, 2025

Dec 02, 2025

ProMIS Neurosciences announces publication on plasma pTau in Alzheimer’s - MSN

Dec 02, 2025

Dec 02, 2025

ProMIS Neurosciences target adjusted to $18 from $4 at H.C. Wainwright - MSN

Dec 02, 2025

Dec 02, 2025

ProMIS Neurosciences Shares Advance After New Data Supports Alzheimer’s Trial Strategy - MSN

Dec 02, 2025

Dec 02, 2025

Why hedge funds are buying ProMIS Neurosciences Inc. stockWeekly Trade Recap & AI Based Buy/Sell Signal Reports - Newser

Dec 02, 2025

Dec 02, 2025

symbol__ Stock Quote Price and Forecast - CNN

Dec 02, 2025

Dec 02, 2025

ProMIS Neurosciences stock rises after promising Alzheimer’s research data By Investing.com - Investing.com Australia

Dec 02, 2025

Dec 01, 2025

HC Wainwright & Co. Maintains ProMIS Neurosciences (PMN) Buy Recommendation - Nasdaq

Dec 01, 2025

Dec 01, 2025

ProMIS Neurosciences Inc (23J0.DU) Valuation Measures & Financial Statistics - Yahoo! Finance Canada

Dec 01, 2025

Dec 01, 2025

PMN: HC Wainwright & Co. Raises Price Target and Maintains Buy R - GuruFocus

Dec 01, 2025

Dec 01, 2025

ProMIS Neurosciences (PMN) Sees Revised Price Target from H.C. W - GuruFocus

Dec 01, 2025